No new safety concerns were reported to date in those individuals, the FDA said.
CDC shortens waiting period for Pfizer booster
The agency also recommends third doses of COVID-19 vaccine for immunocompromised children as young as 5.
No new safety concerns were reported to date in those individuals, the FDA said.
